Lung Cancer : Review in-depth clinical information, latest medical news, and guidelines on lung cancer, specifically small-cell lung cancer and non-small-cell lung cancer. Read the latest ...

A 70-year-old man with non-small-cell lung cancer presented to the clinic with fatigue and dizziness for 1 month. He complained of weight loss (5-10 pounds) and anorexia, and his wife …

Patients who have immune-related adverse events when treated for non–small cell lung cancer (NSCLC) may live longer than those without these complications, according to a new study.

The US Food and Drug Administration has granted accelerated approval to tarlatamab-dlle (Imdelltra, Amgen) for extensive-stage small cell lung cancer (SCLC) with disease progression …

Dr Kris reviews the latest treatment advances in small cell lung cancer, including new standards of care and emerging therapies in 2024.

A preventative and proactive dermatologic regimen reduces skin and nail adverse reactions in patients with EGFR-mutant NSCLC receiving first-line treatment with amivantamab plus …

Some tumors, such as Hodgkin's lymphoma and small cell lung cancer, are very sensitive to chemotherapeutic agents, whereas lymphoma and myeloma are more radiosensitive, and …

Merck has started a new campaign featuring TV actress Bellamy Young to prompt people with non-small cell lung cancer to have their tumors tested for biomarkers.

Dr Mark Kris continues his series “It’s Complicated,” focusing on patients who do not have a target based on standard NGS testing.

Lung cancer is the primary etiology of malignant nodules and is the most common cause of cancer-related death in both sexes.